Podiatry care and amorolfine: An effective treatment of foot distal onychomycosis

A. Zalacain*, L. Ruiz, G. Ramis, V. Novel, J. M. Ogalla, M. A. Calvo, T. Vinuesa

*Corresponding author for this work

    Research output: Contribution to journalArticleResearchpeer-review

    1 Citation (Scopus)


    Background: Onychomycosis constitute more than 40% of onychopathies in humans. Several suggestions have been published to standardize the treatment protocols. Objectives: The aim of this study was to evaluate the risk factors for onychomycosis as well as to compare laboratory and clinical data and to determine the effectiveness of amorolfine in the treatment. Method: Samples were obtained from 360 patients and processed in the laboratory. Treatment and improvement of lesions were followed up for 6 and 9 months in all cases. Results: T. mentagrophytes and T. rubrum the most common dermatophytes whereas among non-dermatophytes the order of incidence was Scopularopsis brevicaulis, Acremonium roseum, Aspergillus spp., and Fusarium sp. Onychomycosis was successfully treated by amorolfine in 75.3% of cases. © 2006 Elsevier Ltd. All rights reserved.
    Original languageEnglish
    Pages (from-to)149-152
    Number of pages4
    Issue number3
    Publication statusPublished - 1 Sep 2006


    • Amorolfine
    • Fungal isolation
    • Fungal susceptibility
    • Improvement
    • Onychomycosis


    Dive into the research topics of 'Podiatry care and amorolfine: An effective treatment of foot distal onychomycosis'. Together they form a unique fingerprint.

    Cite this